Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae - PubMed (original) (raw)

Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae

D E Briles et al. Infect Immun. 2000 Feb.

Abstract

Acquisition of pneumococci is generally from carriers rather than from infected individuals. Therefore, to induce herd immunity against Streptococcus pneumoniae it will be necessary to elicit protection against carriage. Capsular polysaccharide-protein conjugates, PspA, and PsaA are known to elicit some protection against nasopharyngeal carriage of pneumococci but do not always completely eliminate carriage. In this study, we observed that PsaA elicited better protection than did PspA against carriage. Pneumolysin elicited no protection against carriage. Immunization with a mixture of PsaA and PspA elicited the best protection against carriage. These results indicate that PspA and PsaA may be useful for the elicitation of herd immunity in humans. As PspA and pneumolysin are known to elicit immunity to bacteremia and pneumonia, their inclusion in a mucosal vaccine may enable such a vaccine to prevent invasive disease as well as carriage.

PubMed Disclaimer

Cited by

Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria.
Zhang Q, Finn A. Zhang Q, et al. J Clin Pathol. 2004 Oct;57(10):1015-21. doi: 10.1136/jcp.2004.016253. J Clin Pathol. 2004. PMID: 15452151 Free PMC article. Review.
Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A.
Oliveira ML, Arêas AP, Campos IB, Monedero V, Perez-Martínez G, Miyaji EN, Leite LC, Aires KA, Lee Ho P. Oliveira ML, et al. Microbes Infect. 2006 Apr;8(4):1016-24. doi: 10.1016/j.micinf.2005.10.020. Epub 2006 Jan 18. Microbes Infect. 2006. PMID: 16549380 Free PMC article.
Enhanced protection against nasopharyngeal carriage of Streptococcus pneumoniae elicited by oral multiantigen DNA vaccines delivered in attenuated Salmonella typhimurium.
Zhang Q, Ma Q, Li Q, Yao W, Wang C. Zhang Q, et al. Mol Biol Rep. 2011 Feb;38(2):1209-17. doi: 10.1007/s11033-010-0219-7. Epub 2010 Jun 19. Mol Biol Rep. 2011. PMID: 20563651
Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection.
Moreno AT, Oliveira ML, Ferreira DM, Ho PL, Darrieux M, Leite LC, Ferreira JM Jr, Pimenta FC, Andrade AL, Miyaji EN. Moreno AT, et al. Clin Vaccine Immunol. 2010 Mar;17(3):439-46. doi: 10.1128/CVI.00430-09. Epub 2010 Jan 20. Clin Vaccine Immunol. 2010. PMID: 20089795 Free PMC article.
Th17 responses to pneumococcus in blood and adenoidal cells in children.
Oliver E, Pope C, Clarke E, Langton Hewer C, Ogunniyi AD, Paton JC, Mitchell T, Malley R, Finn A. Oliver E, et al. Clin Exp Immunol. 2019 Feb;195(2):213-225. doi: 10.1111/cei.13225. Epub 2018 Oct 31. Clin Exp Immunol. 2019. PMID: 30325010 Free PMC article.

References

1. Abeyta M. Pneumococcal surface protein A and capsular polysaccharides in virulence of Streptococcus pneumoniae. Thesis. Birmingham.: University of Alabama at Birmingham; 1999.
1. Alexander J E, Berry A M, Paton J C, Rubins J B, Andrew P W, Mitchell T J. Amino acid changes affecting the activity of pneumolysin alter the behavior of pneumococci in pneumonia. Microb Pathog. 1998;24:167–174. - PubMed
1. Alexander J E, Lock R A, Peeters C C A M, Poolman J T, Andrew P W, Mitchell T J, Hansman D, Paton J C. Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect Immun. 1994;62:5683–5688. - PMC - PubMed
1. Benton K A, Paton J C, Briles D B. Differences in virulence of mice among Streptococcus pneumoniae strains of capsular types 2, 3, 4, 5, and 6 are not attributable to differences in pneumolysin production. Infect Immun. 1997;65:1237–1244. - PMC - PubMed
1. Benton K A, Paton J C, Briles D E. The hemolytic and complement-activating properties of pneumolysin do not contribute individually to virulence in a pneumococcal bacteremia model. Microb Pathog. 1997;23:201–209. - PubMed

Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae - PubMed (original) (raw)